| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.042 | 0.4 |